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ABSTRACT 
EFFECT OF SOCIO-CULTURAL BELIEFS ON LATE STAGE PRESENTATION OF BREAST 
CANCER AMONG GHANAIAN WOMEN. Yehoda M. Martei; Verna Vanderpuye; and Beth A. Jones.  
Yale University, School of Medicine, New Haven, CT. 
New data emphasizes the increasing burden of cancer in the developing world, which has led to an 
increasing move to prioritize cancer care on the global health agenda. Breast cancer is the leading cause of 
cancer mortality among women globally. In Ghana, most women present with advanced stage breast 
cancer. There is currently no national screening program, and insight into why women present late stage is 
limited. The aim of this study is to characterize why women present with advanced stage breast cancer in 
Ghana.  
We used a Qualitative study based on in-person and in-depth interviews with 31 breast cancer 
patients seen at the Korle-bu Teaching Hospital in Ghana. The interview data was transcribed, and coded 
based on the Grounded theory method. Data was organized using NVivo 9 software. 
Five recurrent themes emerged from our study with four explicitly related to late stage at 
presentation: 1) Study participants expressed some awareness of breast cancer, but with varying depths of 
knowledge; 2) most patients present late because they do not associate a “painless” breast lump with 
possible breast malignancy; 3) women with a confirmed breast cancer diagnosis, delay treatment because of 
the fear of mastectomy; 4) religion plays an important supportive role for breast cancer patients. 5) A fifth 
factor was not explicitly related to delayed presentation. Breast cancer treatment presents a significant 
financial burden but was not stated as an explicit reason for delayed presentation. We concluded that 
despite efforts to increase awareness, there are still significant knowledge gaps, and social and cultural 
factors that need to be addressed to enable patients translate this information to their personal health. The 
church’s current role can be leveraged to augment current efforts to increase breast cancer awareness and 
utilization of the current services available. Successful design and implementation of cancer programs 
hinge on attention to socio-cultural influences on advanced stage presentation.  
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INTRODUCTION 
 
The International Agency for Research on Cancer (IARC)’s most recent cancer 
statistics indicate that the majority of the 12.8 million new cancer cases (56%) and the 7.6 
million cancer deaths (63%) worldwide occurred in developing countries. In developing 
countries, more people develop (7.1million) and die from cancer (4.8million) each year 
than are affected or die from HIV/AIDS throughout the world (an estimated 2.7 million 
and 2 million respectively in 2008) (1, 2). These new data emphasize the increasing 
burden of cancer in the developing world, which has led to an initiative by significant 
global health players to move cancer on the global health agenda (3). However, there is 
still a ring of silence surrounding cancer diagnoses in the developing world and 
preliminary studies are needed to examine the perceptions of cancer in order to design 
culturally appropriate and effective cancer control programs in the developing world. 
 
Breast Cancer in Ghana 
Breast cancer is the leading cause of cancer mortality among women globally. 1.1 
million women in the world are diagnosed annually with breast cancer, which accounts 
for more than 10% of all new cancers diagnosed per year (4). 410,000 women die of 
breast cancer every year, which represents more than 1.6% of all female deaths 
worldwide (5, 6). The IARC estimated WHO age-world standardized-incidence rate 
(ASR (W)) for breast cancer in 2008 among women in the United States is 76.0. For the 
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same year, the age-world-standardized mortality rate for breast cancer in the United 
States was 14.7. The IARC calculates the ASR (W) by dividing the number of cases 
within a specified age-group with the corresponding population at risk and is expressed 
per million person-years. The IARC estimates for Ghana were ASR(W) incidence rate of 
25.8 and ASR(W) mortality rate for breast cancer of 15.2 in 2008 (7). These data 
underscore the fact that despite the significantly lower incidence rate of breast cancer 
among Ghanaian women relative to American women, the breast cancer mortality burden 
of the two countries are comparable.  
In most developing countries, including Ghana, the incidence rate of breast cancer 
is comparatively low compared to western countries. Consequently, breast cancer and 
other cancers are not traditionally recognized as public health problems in these 
countries. Infectious diseases are the main focus and target of public health interventions 
in a majority of these countries (1, 3). In recent years however, the incidence rate of 
breast cancer in developing countries has been increasing at approximately 5% per year 
(8). The earliest study of breast cancer in Ghana revealed that breast cancer accounted for 
7.45% of all cancers treated from 1972 to 1977 at the Korle-Bu Teaching hospital 
(KBTH), one of the two main teaching hospitals in Ghana (9). Ghana does not have a 
national tumor registry, so these data represent only breast cancer cases that come to 
medical attention at the KBTH and cannot be extrapolated to represent the incidence of 
breast cancer in Ghana. These data are useful for evaluating trends in cancer cases seen at 
KBTH. The most recent data showed an increase in the relative proportion of breast 
cancer cases, with breast cancer accounting for 15.4% of all malignancies seen at the 
KBTH (10). A 10 year review (1991-2000) of autopsies and hospital mortality carried out 
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in Ghana showed a parallel increase in breast cancer mortality - 17.24% of cancer deaths 
among women were attributable to breast cancer (11). All these point to an increasing 
burden of breast cancer in Ghana, which is consistent with current statistics that show an 
increasing trend in breast cancer incidence and mortality in developing countries globally 
(7). 
Despite the relatively lower incidence of breast cancer among Ghanaian women, 
the mortality rates for breast cancer are comparable or even higher in the Ghanaian 
population compared to the US population (7). This observation can be explained by 
several factors. Majority of the breast cancer patients in developing countries present 
with advanced stage cancer, and consequently have a poor prognosis when they are 
initially diagnosed (8, 12). Studies indicate that women who attend annual screening 
mammograms present with smaller size tumors, which in the long-term accounts for 
improvement in survival (13, 14). It can be accurately inferred that a significant fraction 
of the high mortality rate in Ghana can be explained by the underutilization of 
mammography screening and other screening modalities among Ghanaian women. 
Recent studies have also compared breast cancer presentation and mortality patterns 
between African Americans and Africans. In both populations, the breast cancer 
mortality is disproportionately higher than the incidence. Similarly, the average age at 
presentation for Africans and African Americans, was 10 years younger than the average 
age at presentation of breast cancer patients in western nations. Data available for African 
American breast cancer patients, show a stage shift toward more advanced disease, which 
resulted in higher breast cancer mortality. New data has also shown the genetic 
predisposition to more aggressive disease in the African American population. Whether 
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this contributes to advanced stage presentation and increased breast cancer mortality in 
Sub Saharan Africa remains uncertain (15).  
 
Breast Cancer Mammography Screening 
The commonest screening technique used in the detection of breast cancer 
globally is screening mammography (16). Previous studies in the US and other Western 
countries have shown that a significant fraction of the decrease in the breast cancer 
mortality in the last couple of decades can be attributed to mammography screening. In 
the US, approximately 48% of the decline in breast cancer mortality experienced from 
1975-2000 can be accounted for by screening mammography (13). Similarly in the UK, 
about a third of the overall 21% decrease in breast cancer mortality from 1990-1998 is 
estimated to be due to screening (14). The recent controversy surrounding the revised 
screening guidelines by the United States Preventive Services Task Force (USPSTF) does 
not dispute the mortality benefit of mammography screening, but instead, they 
recommend against screening for women younger than 50 years and older than 75 years, 
because there is insufficient data to support mortality benefit in these age groups (17). 
Despite the net mortality benefit of mammography screening, research preceding these 
new screening recommendations show that most women in the US do not adhere to the 
screening guidelines (18-22).  
There is no national mammography screening program instituted in Ghana. The 
main modalities of screening are the Clinical Breast Examination (CBE) and Breast Self-
Examination (BSE). Previous studies show no mortality benefit of the BSE and there are 
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currently no randomized trials of the CBE (23). Currently, the USPSTF does not endorse 
both modalities of screening (17), but in the absence of routine screening mammography 
in Ghana, most breast cancers are picked up by the BSE and CBE. There has been a 
recent surge in public education programs about breast cancer and available screening 
options, as well as organized mass CBE screening outreach programs organized by both 
the government (national teaching hospitals) and non-governmental organizations 
(NGOs) (such as Mammocare Ghana and Reach for Recovery). The KBTH is located in 
Accra, the capital city of Ghana, and organizes free CBE a couple of days within the 
year. Mammocare Ghana is an NGO that promotes breast cancer and screening 
awareness. This NGO organizes free CBE screening through outreach programs. Reach 
for Recovery Ghana is an NGO that provides a network of support for breast cancer 
patients and survivors. They also organize annual breast cancer information sessions to 
promote breast cancer awareness and early detection. In spite of these provisions, 
mammography screening and CBE continue to be significantly underutilized among 
Ghanaian women (12). The average tumor size at presentation among breast cancer 
patients in Ghana is 6-7cm (12), compared to an average tumor size of 1.4cm and 1.9cm 
among US women aged 50-60years and <40years respectively (24). This raises the 
concern that women are not getting screening mammograms and CBEs. It further 
indicates that although the Ghanaian government and NGOs are making screening more 
accessible and available, the actual uptake of screening services by the population 
remains poor. Successful implementation of any screening intervention necessitates an 
assessment of breast cancer awareness within the population and an analysis of the 
factors that explain why women present with advanced stage breast cancer. Current 
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research also suggests that even in instances where women have a confirmed diagnoses 
of breast cancer, treatment follow-up is poor (25). The reasons for this remain unclear, 
but are most likely socio-cultural and socioeconomic-related, and have yet to be 
described.  
 
Previous Studies 
A Pubmed search for publications related to Ghana and breast cancer yielded 
limited results. Few studies have looked at the knowledge of breast cancer and breast 
cancer screening among women in Ghana (25). Studies in other parts of sub-Saharan 
Africa have looked at perceptions of breast cancer and the depth of breast cancer 
knowledge among women in Africa. The results revealed that women knew very little 
about breast cancer (26-30). Additionally, less than half of family physicians and nurses 
surveyed, said they regularly carried out or recommended breast cancer screening to their 
patients (27, 31).  
Although evidence indicates several obstacles to diagnosis and management of 
breast cancer in Ghana, information to characterize the socio-cultural phenomenon is 
lacking. The goal of this study is to understand the degree of breast cancer awareness 
among a subset of women diagnosed with breast cancer. This study also aims to allow 
participants to describe how their knowledge of breast cancer and socio-cultural factors 
influenced their decision to present with symptoms and to follow up with breast cancer 
treatment. The importance of this study is underscored by the fact that despite the wide 
acceptance of breast cancer screening and the extensive public awareness of breast cancer 
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among the American public, many women do not receive regular mammograms 
according to screening guidelines (32-34). A significant body of research related to 
mammography screening in the US has been directed towards understanding the 
screening patterns specific to different ethnic groups (35-38). Similarly this study will 
shed light on the specific factors associated with late presentation of breast cancer 
symptoms and play a pivotal role in the future design and implementation of educational 
tools for breast cancer screening and management in Ghana. 
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METHOD 
 
Study Design 
This study used qualitative methodology as a preliminary vehicle for investigating 
the above research question, because qualitative methods are well suited for studies for 
which there is a paucity of prior research (39). Few studies have explored the knowledge, 
attitudes and beliefs of breast cancer patients in Ghana. While previous investigators have 
used a questionnaire based approach, we believe the qualitative method is more effective 
in revealing salient insights into socio-cultural and socioeconomic factors that impact 
breast cancer, and specifically their impact on late breast cancer presentation (40). The 
qualitative approach also employs open-ended questions which allow the interviewer to 
re-word and re-order questions to explore topics introduced by the respondent (41). In 
this particular study, the qualitative method allows the respondents to explain their 
understanding of breast cancer using their own vocabulary. The results of this qualitative 
study will be useful for generating hypotheses that can be tested with quantitative 
research design (39).We believe this fund of knowledge will inform the design and 
implementation of educational programs to address the diagnosis and management of 
breast cancer in Ghana (40, 42).  
 
Patient Population 
The research protocol was approved by the Human Investigation Committee of 
the Yale University School of Medicine, New Haven, CT (HIC Protocol # 0804003745). 
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The study setting is the outpatient breast clinic at the KBTH staffed by a team of 
surgeons, radiation oncologists, oncology nurses, a clinical psychologist and a clinical 
pharmacist, who meet every Tuesday to discuss self-referred patients. The clinic also 
serves as a follow-up center for patients with confirmed breast cancer diagnosis 
undergoing treatment.  
31 study participants were selected using purposive sampling (39). Women with a 
confirmed breast cancer diagnoses, who were attending routine follow-up appointment at 
the clinic between June 2008 and August 2008, were approached in-person by one of the 
authors (VV), who is a radiation oncologist at the clinic, and asked if they would 
participate in research to study the perception of breast cancer among Ghanaian women. 
In order to address the goal of the study, we selected women with confirmed diagnoses of 
breast cancer. All the study participants had been previously seen at the clinic, and were 
presenting for follow-up. Of note there was variability in the timeline of breast cancer 
management in order to inform a broader understanding of factors that influence 
screening and follow up at different stages of treatment. All the women who were 
approached agreed to participate in the study, and were then introduced to the interviewer 
(YMM), who explained the study in detail. Participants were reluctant to give written 
consent, so verbal consent was obtained for all study participants, and consenting patients 
were interviewed at the clinic.  
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Interview and Data Collection 
The interviews were conducted in English and three local Ghanaian languages – 
Twi, Ga and Ewe. There were no third parties present for any of the interviews, except 
for one interview in which the study participant’s daughter was present and served as an 
English-Ewe translator. The interviewer (YMM) was fluent in the other languages – Twi 
and Ga. The study participants were asked a series of open-ended questions about their 
general health and wellbeing, previous encounters with the healthcare system, knowledge 
of breast cancer, screening, presentation and treatment course, as well as their feelings 
about their diagnosis, and religious and socio-cultural influences relevant to their recent 
breast cancer diagnoses. The iterative process was used for this study. Preliminary data 
analysis of earlier interviews occurred concurrently with data collection, and the 
interview questions in subsequent interviews, were modified based on emerging themes 
(42). Questions were optimized during this process in order to retain only questions that 
were effective in eliciting the necessary information. A mix of both planned and 
unplanned follow-up questions were carefully considered to continue the conversation 
and were primarily directed by the respondent’s knowledge and interests (40). In this 
setting where the vocabulary for breast cancer is not directly translatable to the local 
languages, the translations during the interviews were descriptive and the meanings of the 
questions were clarified by allowing the respondents to first express the understanding of 
the question in their own words before answering the question. Questions were 
paraphrased as many times as needed to ensure a uniform understanding among the study 
participants. No repeat interviews were carried out. Figure 1 shows the semi-structured 
interview guide. All but three interviews were anonymously recorded using a digital tape 
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recorder. Three participants objected to taped interviews, so the interviewer took notes 
during these interview sessions, including verbatim quotes. The interviews lasted an 
average of 45 minutes. Recorded interviews were then transcribed by an independent 
transcriptionist. Interviews conducted in English were transcribed verbatim. Interviews 
conducted in languages other than English were translated and transcribed. The 
transcriptions were translated, back translated and reviewed by the interviewer (YMM) to 
establish accuracy of the data. The interviewer was fluent in Twi and Ga, but not Ewe. 
 
Data Analysis 
Data were analyzed according to principles of Grounded Theory methodology 
(39), with the aim to generate hypotheses from the data. All transcribed interviews were 
entered and organized using NVivo 9. Each interview was coded by two independent 
coders – the interviewer (YMM) and two independent coders. The data were coded using 
‘open coding.’ The interviews were coded line by line and a theme was assigned based on 
the understood meaning. In order to determine the accuracy of the code assigned, 
throughout the analyses the coders compared the segment pertaining to a certain code 
with previously coded segments with the same code and analyzed whether they reflected 
the same theme, in a process called “constant comparison” (42). The independently coded 
interviews were then compared for agreement of the coding assigned. Where there was a 
disagreement, the code assignments were discussed between the two coders and the 
interviewer, to establish an accepted agreement. All coded interviews were uploaded into 
Nvivo 9, and we used the query tool to compare the level of agreement between coders 
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for each of the interviews. There was at least 80% agreement between coders for each of 
the interviews (42). We sought to ensure the credibility and reliability of the data by 
providing an “audit trail’ to the other researchers that is by monitoring and reporting data 
collection and analytical processes and procedures fully (39). Reliability was established 
by using more than one coder and by review and discussion of the codes among the three 
coders, as needed.  
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RESULTS 
 
Study participants represented a range of ages, geographical locations and 
different stages of breast cancer management (Table 1). Five recurrent themes 
characterized the knowledge, beliefs and attitudes about screening mammography and 
four were specifically related to why women delay with breast cancer presentation. A 
summary of the major themes is presented in Table 2: 1) Most of the women in our study 
expressed some, but variable degrees of breast  cancer knowledge and screening 
recommendations but were unable to translate this information to their personal health; 2) 
Symptomatic women often delayed with presentation because they did not associate a 
breast lump with breast cancer, often mistaking the lump for a common “boil;” 3) When 
diagnosed with breast cancer, most of the study participants failed to follow up for timely 
treatment because of the fear that a mastectomy would lead to death and diminished 
sexuality; 4) Although not directly associated with late presentation of breast cancer, the 
church plays a pivotal role in dissemination of information on breast cancer screening, 
referral to oncologists, and provision of emotional and spiritual support during breast 
cancer diagnosis and management. For some women the church aided in their decision to 
present for breast cancer management; 5) When specifically asked about the influence of 
financial limitations on delayed presentation, the study participants discussed the high 
cost of chemotherapy treatment. Only two of the respondents explicitly stated treatment 
costs as a reason for late presentation. Most of the women in our study had purchased 
into the National Health Insurance Scheme (NHIS) introduced by the Ghanaian 
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government, and stated that this insurance covered part of the cost of surgical 
management, diagnostic imaging and laboratory work, but not chemotherapy and 
radiation, which they believed were the most costly aspects of breast cancer management. 
We provide verbatim quotations to illustrate each theme. 
 
Theme 1: 
Most of the women in our study expressed some, but variable degrees of breast cancer 
knowledge and screening recommendations but were unable to translate this information 
to their personal health. 
 
 Prior to their diagnoses, all but two of the study respondents had heard some 
information about breast cancer. The main sources of information identified were the 
media (i.e. television or radio) and church-organized health outreach programs. When 
asked about knowledge of breast cancer and screening recommendations prior to 
diagnosis, one of the study participants said, “I even saw it on a TV program, “Mmaa 
Nkomo.” They said women should check every morning for lumps. But when I wake up, 
I don’t even think there will be anything there… so I don’t’ check.” Another said, “I 
heard an announcement on the radio that all women should go to Korle-Bu [the teaching 
hospital where this study was conducted] to have their breasts checked. It was announced 
on Peace FM.” Some of the respondents identified church-organized programs as their 
source of information, “they come and tell us in the church, before I know that there is 
something like that [breast cancer] to check the breasts.”  
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 The women in our study expressed some awareness of breast cancer but showed 
significant variability in their knowledge. A 77-year old grandmother had this to say, 
“they usually say that when you put money in your brassiere, you can develop it,” while a 
bank executive had this to say, “my knowledge is scanty… all I know is that you can 
have some cancerous cells developing, that can start with a lump or something and then it 
grows into something else. And then if they detect the lump quickly enough they remove 
it and you’re ok, but if it has spread then you have to have another form of surgery. 
Sometimes people lose their breasts and they go through chemotherapy and if they’re 
able to detect it early enough, it’s treatable, but once it’s advanced there’s no cure for it, 
you probably have to be given medication to slow down the rate at which it spreads.” A 
few women assigned spiritual causes to the disease. One of the study participants who 
had sought interim treatment from a traditional herbalist was told that her breast cancer 
was a result of a spell:  “he said my husband fought with somebody and that, that person 
[cast a spell]… so the spell was meant for my husband but it did not get him so it 
attacked me.”  
 Regardless of the depth of knowledge about breast cancer, the study participants 
explained that breast cancer is not discussed in social circles. This silence is further 
perpetuated by current breast cancer patients and survivors, who refuse to discuss their 
diagnoses. One of the study participants explained that, “I had heard about it [breast 
cancer] but I had not seen it with my eyes. I didn’t know anyone who had it….” Another 
participant explained that, “I was shy because people would have said that I had brought 
a curse on the family especially because it had never happened to anyone. That’s why I 
didn’t tell anyone.” The women in our study also commented on the fact that discussing 
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their diagnosis inspires gossip. One participant explained, “for some people [breast 
cancer patients]... there are spiritual forces [causes] too so you shouldn't talk about it;” 
and another explained, “if I should tell them [network of friends], they would be 
consumed with fear and there will be too much gossip. I don't want things to spread.” 
 
Theme 2: 
Symptomatic women often delayed with presentation because they did not associate a 
breast lump with breast cancer, often mistaking the lump for a common “boil.” 
 
 Despite some knowledge of breast cancer and screening, most women did not 
present with early with breast cancer symptoms. All study participants presented with a 
lump and/or some other breast symptom, which most mistook for a “boil.” A boil, which 
is a “a localized swelling and inflammation of the skin resulting from usually bacterial 
infection of a hair follicle and adjacent tissue, having a hard central core, and forming 
pus—called also furuncle (43),” is a fairly common occurrence among Ghanaians (across 
the entire population) and it usually resolves spontaneously or after a couple of 
applications of western or traditional/herbal topical treatment. One of the participants 
who presented five years after noticing her lump said, “It was long ago, about 5 years 
ago. But all that while, it was not painful so I used to say it’s just a boil, it will go away 
eventually,” and another expressed a similar opinion, “I thought it was a boil and so I was 
applying the medicine for boils but it wasn't going away.” 
 All study participants expressed shock at their diagnosis, and it was inconceivable 
to them that what had initially started out as painless breast lump turned out to be breast 
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cancer. To summarize, one patient said, “it [the breast lump] was just there, it wasn’t 
painful, and no fluid came out of it. So I became surprised because it didn’t seem to 
match with any of the breast cancer symptoms that you hear, such as fluids coming out of 
the breasts, the color of the breast changing, etc.”  
 
Theme 3: 
When diagnosed with breast cancer, most of the study participants did not follow up with 
timely treatment because of the fear that a mastectomy would lead to death and 
diminished sexuality. 
 
 A recurrent theme that emerged in our study was that when women presented to 
the hospital and saw an oncologist, who established their breast cancer diagnosis, most of 
these women, did not adhere to timely management or absented themselves for varying 
lengths of time, before re-presenting at the hospital. This was attributed to the fear of 
mastectomy. When probed directly about the fear of mastectomy, women explained that 
they believed mastectomy was associated with death. One woman explained, “I thought 
because our breasts were next to our chest, one will die when one’s breast gets cut off.” 
Another study participant said, “I understand when you do the surgery you will die… so 
when I was at the surgical ward, they even booked me for that surgery and I run away.” 
 Another fear of mastectomy which women expressed very passionately was the 
diminished sexuality a woman experiences after mastectomy. An 85 year old widow, who 
consented to a mastectomy with little protest, had this to share about the implication of a 
mastectomy for younger patients,  “I saw young ladies like you who had it [breast cancer] 
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and it was very sad because I was thinking there is no way they will get anyone to marry 
them. Some of them had one breast. If you have one leg, or one hand you get someone to 
marry you but without a breast, you won’t get anyone to marry you! If you don’t have a 
husband it is very difficult. That is why the doctor said it is so bad to get the sickness 
[breast cancer] at a young age.” One woman in our study whose final decision was to 
forgo mastectomy expressed her concern in this way, “a woman's glory is her breast, so 
what is your use if one of your breasts is not there? I will rather die with my two breasts 
than live with one.” There was one case in which a woman who had initially consented to 
a mastectomy expressed regrets about the procedure because of the impact of the surgery 
on her marriage. She reported, - “my husband even wanted a divorce because he said I 
had been maimed.” 
   
Theme 4: 
Although not directly associated with late presentation of breast cancer, the church plays 
a pivotal role in dissemination of information on breast cancer screening, referral to 
oncologists, and provision of emotional and spiritual support during breast cancer 
diagnosis and management. Some respondents stated that the church aided in their 
decision to present for breast cancer management. 
 
 All of the women in our study identified with a religious group. All but one, who 
was a Muslim, identified as Christians. Most of the respondents attended church/mosque 
on a regular basis. Although the women in our study did not directly mention the church 
(or their faith) as reason for delayed presentation, a recurrent theme was the influential 
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role of the church during various stages of their diagnosis and management. For most 
participants, the church was aware of their breast symptoms and involved in some aspect 
of their disease prior to presentation to the hospital. For some of these women, a church 
leader, or an individual in church encouraged them to present to the hospital with their 
symptoms or recommended them to an oncologist at the KBTH clinic. One of the study 
participants stated that part of the reason why she eventually presented to the hospital 
with the breast lump was, “when I showed it to the nursing sister at church, she even told 
me that it wasn’t really anything and that the doctors could operate on it and have me 
come back home right away but the tests showed that it was cancerous even though it was 
small.” Another study participant stated that: “I told my pastor and then he recommended 
Dr. X.” And even for those who independently arrived at the decision to seek medical 
follow-up, they still turned to the church for support before presenting to the hospital. 
One of the study participants said, “I told my superintendent minister and my pastor, who 
prayed for me before coming to Korle-Bu [the teaching hospital where this study was 
conducted].” 
 Although the study participants had expressed their reluctance to discuss their 
diagnoses publicly or within social circles, our study reveals that women diagnosed with 
breast cancer felt confident in discussing their diagnosis with church affiliates. One study 
participant when specifically asked about this said, “Only the pastor knows. I've told 
other people I'm sick but only the pastor knows exactly what is going on.” 
  
Theme 5: 
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When specifically asked about the influence of financial limitations on delayed 
presentation, the study participants discussed the high cost of chemotherapy treatment. 
Only two of the respondents explicitly stated treatment costs as a reason for late 
presentation. Most of the women in our study had purchased into the National Health 
Insurance Scheme (NHIS) introduced by the Ghanaian government, and stated that this 
insurance covered part of the cost of surgical management, diagnostic imaging and 
laboratory work, but not chemotherapy and radiation, which they believed were the most 
costly aspects of breast cancer management.  
 
 Given that Ghana is a resource-poor country, the study participants were asked 
directly how cost of care influenced delayed presentation. Only two of the study 
participants identified this as a reason for absenting themselves or delaying treatment. 
One of the study participants expressed this financial barrier as such: “Immediately I 
went to the lab and came here, they immediately scheduled me for surgery. I didn’t have 
money so I went home and never came back because I didn’t have money… I run away 
because of the money.” One of the study participants, a trader, explained the difficult 
financial choice she had to make, which subsequently resulted in her delayed 
presentation:  “…at the time I discovered this lump in my breast, my daughter had just 
been accepted into Legon [one of three main universities in Ghana] to study nursing… I 
didn’t come [follow up with treatment] because I wouldn’t have been able to work to 
provide [financially] for my child and I would have destroyed her life…  so I wanted to 
her to go because I knew that even if I had passed away, she would have entered the 
University.” 
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 Most of the study participants however, discussed the enormous financial burden 
of cancer management and specifically remarked that chemotherapy drugs were too 
expensive. Majority of the study participants who were in low-income jobs received 
significant financial assistance from the church. When probed about the extent of 
financial assistance offered by the church, one of the study participants said, “so they 
gave me my bill [for chemotherapy] and I gave it to the church so they appealed for funds 
and that is what I used to pay it off. I paid 425 GH¢ cedis [~$300]” 
 Almost all the women indicated that they had purchased the NHIS, however they 
expressed frustration regarding the limited coverage of this insurance plan. To summarize 
the general theme, one study participant said, “I have health insurance but it doesn’t 
cover much. It covers x-ray and it covers lab. But it doesn’t cover anything here [i.e. 
chemotherapy and radiation therapy]. 
 
 Specific questions with regards to transportation revealed that 25.8% of study 
participants traveled from outside of Accra, to seek treatment at the Korle-Bu Teaching 
Hospital, which is located in the capital city, Accra (Table 1). Consequently, these 
patients had to make arrangements for home care and also arrangements for housing 
while in Accra for treatment. However, this was not explicitly stated by any of the 
women in our study as a reason for delayed presentation and management. 
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DISCUSSION 
  
 We found that all respondents had some prior knowledge of breast cancer through 
the media (i.e. television and radio) and church outreach programs. However, none of the 
study participants attended screening (either screening mammograms or clinical breast 
exams) and consequently these patients presented with late stage disease. An interesting 
fact to note is that 41.9% of the patients in our study were diagnosed before age 40 (Table 
1), and would not have met current recommendations for screening. In all cases patients 
had a palpable lump or other breast symptom at the time of presentation. 96.8% of study 
participants presented with at least a breast lump (Table 1). We found that lack of 
familiarity with the association between a breast lump and breast cancer, and fear of 
mastectomy, were the main reasons why women delayed with breast cancer presentation 
and timely management respectively. Although a previous study (25) had documented 
reasons why women report late or do not return for treatment, our findings provide 
further insight into the complex ways in which social factors and cultural beliefs interact 
and result in delayed presentation and follow up for surgical and medical management of 
breast cancer. 
 Our findings suggest there is some breast cancer awareness. The fact that women 
delay with presentation indicates that the information received does not accurately 
translate into action with respect to their personal health. The recurrent belief that a 
painless breast lump is unlikely to be breast cancer, suggests a need to improve 
knowledge about breast cancer symptoms in this population. Our findings also suggest 
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that despite the availability of information, there is no talk of breast cancer in social 
circles, with most women stating that they have never seen anyone with breast cancer. 
This lack of an informed social network may contribute to the knowledge deficit, 
particularly the tendency to think of breast lumps as relatively harmless rather than a 
symptom of breast cancer. This could explain the gap between some breast cancer 
awareness and the inability of study participants to translate this awareness into 
meaningful health benefit (i.e., with respect to early detection) on an individual level.  
 This study also provides important insights as to why mastectomy is not widely 
accepted and may contribute to delay in presentation when symptomatic and avoidance of 
surgical management once a diagnosis of breast cancer has been confirmed. To our 
knowledge, no study has described the role of sexuality as a prominent barrier to 
diagnosis and treatment of breast cancer within this population. 
 Given the recent reports of interest in cancer in developing countries, and new 
efforts to put cancer management as well as other chronic diseases on the global health 
agenda, our findings have important implications for the design and implementation of 
sustainable and effective breast cancer control programs. Specifically for Ghana, this 
research provides information that may identify the deficits in the existing breast cancer 
education, screening and management efforts by the government and NGO’s. Our 
findings suggest that the church has a positive influence on women’s decisions to present 
and follow up with breast cancer management. The church is also a safe space for breast 
cancer dialogue. Although most women were uncomfortable discussing their breast 
cancer diagnosis with extended family and friends, some of them shared information 
about their diagnosis with their religious leaders. It is therefore perceivable that women 
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would benefit from a network of breast cancer patients and survivors who are members of 
their religious group. Although only a few women mentioned an association with a 
survivor’s support group, a religious-centered survivorship program may be well-utilized 
and could aid in diffusing some of the myths and silence surrounding breast cancer. This 
set-up will augment current efforts to provide support for breast cancer survivors. 
Additionally, spiritual, emotional and financial support can continue to be concurrently 
offered by the church for these women with breast cancer.  
 Our study also reveals that most participants had purchased the NHIS, introduced 
by the government of Ghana in 2003. The premium for this insurance scheme ranges 
from GH¢7.2 (~$5) to GH¢48 (~$34). Based on the information gathered, patients 
depend on the insurance coverage of laboratory tests and diagnostic scans, but continue to 
express concern about the financial burden of chemotherapy and radiation management 
of breast cancer. We believe these findings inform future studies of larger populations, 
with the aim to understanding health insurance needs relevant to breast cancer 
management. 
 Although several novel themes emerged from this study, our findings should be 
interpreted in light of the fact that the qualitative study has some limitations: We 
employed purposive sampling to specifically identify women who would inform our 
research question. We only interviewed women seen at the self-referral clinic at KBTH, 
which also represents another level of selection bias. Additionally, the attitudes, 
knowledge, and experiences identified from the patients we studied may not be 
generalizable to the entire population since these are women who, despite delays, 
eventually did present for follow up and management of their breast lump. There is likely 
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an unquantifiable group of women who do not present at all, thus these results cannot be 
extrapolated to the general population. Specifically for non-participants, financial 
hindrance to presentation and management could be even more significant than that 
reported here. Future quantitative studies of larger populations would provide a more 
representative picture of the breast cancer experience of Ghanaian women. 
  
 Our research has several strengths. In person, one-on-one in-depth interviews 
facilitated an open and candid discussion. Additionally, we used several recommended 
strategies to ensure reliability, including audio-taping of almost all the interviews, 
independent development of coding scheme and follow up comparison between coders 
and maintenance of an audit trail to document analytical processes and procedures (39, 
44). 
 
 With new global emphasis on moving cancer care and funding up the global 
health agenda (1, 3, 45), our research highlights that understanding and addressing the 
social and cultural influences on the  breast cancer experience of Ghanaian women, and 
presumably women in other sub Saharan countries, will aid in the design of effective 
cancer control programs.  
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Figure 1: Semi-Structured Interview Guide 
1. What do you know about breast cancer and screening? 
2. What do you believe is the cause of breast cancer? 
3. Tell me about your breast cancer experience? 
a. Probe about screening habits, symptoms at presentation, and time 
course of their diagnosis and treatment.  
b. How long did you wait to see a doctor? Why is that? 
c. How did you feel when you were initially diagnosed, and what 
were your major concerns? Explain what influenced your decision 
to pursue management? 
4. Did you tell others about your breast cancer diagnosis? What exactly did you tell 
them? How has your diagnosis changed the way people perceive you? 
5. What support systems of groups of individuals influenced your decision to present 
and pursue treatment? 
6. How did the cost of care influence your time course of presentation to the clinic 
and your management decisions? 
7. Is there anything else that you can share with me that might better help me 
understand the factors that influenced your delay in presenting and seeking 
care for breast cancer? 
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Table 1:  
Descriptive Data among Recently Diagnosed Breast Cancer Patients Seen at Korle-Bu 
Teaching Hospital, Accra, Ghana between June to August 2008. 
N = 31 (unless otherwise noted) 
 
CHARACTERISTIC n (%) 
Age 
Age Range 
Mean Age (SD) 
Median Age 
Age Groups (years) 
</= 30  
>30- 40  
>40-50 
>50-60 
>60-70 
>70 
 (years) 
25 - 85 
47.12 (31.86 – 62.38) 
48 
(n) 
4 (12.9) 
10 (32.3) 
6 (19.4) 
6 (19.4) 
2 (6.5) 
3 (9.7) 
Breast Cancer Symptoms at Presentation 
(of note, some patients reported multiple 
symptoms; only the first symptom reported 
is recorded) 
Breast lump 
Nipple discharge 
(n) 
 
 
 
30 (96.8) 
3 (9.7) 
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Swelling 
”Heavy breasts” 
Rash 
Burning sensation in breasts 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
Breast Cancer Treatment  
(self-report) 
Neo-adjuvant Chemotherapy 
Adjuvant Chemotherapy 
Lumpectomy 
Mastectomy 
Surgery (extent unknown by patient) 
Therapeutic Radiation 
Awaiting treatment plan 
N = 31 (%) 
 
4 (12.9) 
13 (41.9) 
5 (16.1) 
11 (35.5) 
1 (3.2) 
8 (25.8) 
3 (9.7) 
Occupation 
Hotel clerk/Secretary 
Nurse’s assistant/nurse/pharmacy attendant 
Farmer/Fish monger 
Trader/Retailer 
Banking executive/Marketing manager 
Retired/Unemployed  
Caterer/Seamstress 
N = 31 (%) 
2 (6.5) 
4 (12.9) 
3 (9.7) 
8 (25.8) 
2 (6.5) 
8 (25.8) 
2 (6.5) 
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Teacher 2 (6.5) 
Patient commute to KBTH, Accra 
Participants living in Accra 
Participants living outside of Accra 
 
23 (74.2) 
8 (25.8) 
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Table 2: Summary of Major Themes 
 
1 There is some awareness of breast cancer, but with varying depths of knowledge. 
2 Participants present with late stage breast cancer because of the lack of association 
between breast lump and breast cancer. 
3 Delayed breast cancer treatment is because of the fear of mastectomy. 
4 Religion has a positive influence on breast cancer presentation and treatment. It also 
plays an important supportive role. 
5 Financial reasons were not explicitly related to delayed presentation and treatment. 
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